UK Markets open in 35 mins

Global Intraocular Lens Market valued at $3.9 billion in 2021, is set to witness a growth of 5-6% in the next 5 years but is likely to be impacted by Recession in 2022-23

Medi-Tech Insights
Medi-Tech Insights

Medi-Tech Insights: The global growth in cataract procedures driven by an aging population, the shift from monofocal IOLs to premium IOLs/advanced technology IOLs, the steady growth of monofocal IOLs in line with the procedural market, and favorable reimbursement scenarios in selected key markets are some of the key factors driving the global intraocular lens market.

BRUSSELS, Belgium, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Intraocular lenses (IOLs) are permanent, artificial lenses that are mostly made of silicone, acrylic, or other plastic compositions and can replace the eye’s natural lens to restore both near and distant vision.

The Global Intraocular Lens Market is Likely to Stay Resilient Through the Recession, Though the Value Mix is Expected to be Severely Impacted

Compounding the severe impact of Covid-19, the Russia-Ukraine war has amplified the slowdown in the global economy, which is entering what could become an extended period of feeble growth and elevated inflation. The situation is likely to lead to supply-chain disruptions and the risk of stagflation which might further curtail global economic growth.

Due to the looming recession, patients are expected to delay elective surgical procedures including cataract surgeries until the future of the broader economy looks more promising. In key markets such as the United States, cataract surgeries involving monofocal IOLs are generally fully covered by medical insurance providers or government reimbursement programs whereas implantation of premium or advanced technology IOLs may only be partially covered, with the individual paying out-of-pocket for the non-covered-component. Considering the current economic and financial conditions, patients are expected to be less willing to incur the costs of these private pays or discretionary procedures and may choose to forgo such procedures or products and might consider trading down to more affordable options.

Moreover, in United States, the 2023 Medicare Physician Fee Schedule final rule released by the Centers for Medicare & Medicaid Services (CMS) confirms a ~4.5% cut to surgeons and anesthesiologists, thus harming patient access to needed surgical care. Proposed reimbursement cuts are likely to adversely impact millions of beneficiaries who depend on Medicare to access sight-saving and sight-restoring procedures. However, healthcare insulation in key markets such as the USA is likely to offset the anticipated adverse impact of the recession as most Americans now have health insurance. Payors are also expected to continue to inject capital into the healthcare economy.

Under-penetrated Premium/Advanced Technology IOLs (AT-IOLs) Offer Ample Growth Opportunities in Intraocular Lens Market

The global intraocular lens market is shifting from monofocal IOLs to premium IOLs/advanced technology IOLs. There lies a huge untapped potential market in the premium IOLs/advanced technology IOLs segment as current penetration stands at 7% outside the USA and 14% in USA. The relatively higher pricing of premium IOLs/advanced technology IOLs is expected to drive the IOLs market value in the upcoming years.

Technological Advancements in Intraocular Lens are Driving the Intraocular Lens Market

The global intraocular lens market is expected to be bolstered by recent and consistent technological advancements. For instance,

  • In September 2022, Alcon introduced Clareon Toric IOL at the American Academy of Ophthalmology (AAO) 2022 annual meeting in Chicago, U.S., and completed the Clareon Collection. Clareon Toric is a glistening-free toric intraocular lens with exceptional clarity and unrivaled stability. It was rolled out across select practices in US.

Approximately 2.2 billion people globally suffer from impaired vision, and nearly 20% (200 million) people worldwide suffer vision impairment or blindness caused by cataract or uncorrected refractive error. There is a pressing need to increase manufacturing operations related to IOLs in order to cater to growing eye health needs.-Operations Director, Leading IOL Manufacturer, U.S.

Organic and Inorganic Growth Strategies Adopted by Leading Market Players to Establish Their Strong Foothold in Intraocular Lens Market

The leading players operating in the global intraocular lens market have adopted both organic and inorganic growth strategies such as new product launches, expansion, investments, acquisitions, partnerships to garner a higher market share. For instance,

  • In September 2022, Johnson & Johnson Vision announced the availability of presbyopia-correcting intraocular lens (PC-IOL) powered by InteliLight technology, TECNIS Symfony OptiBlue IOL. The extended-depth-of-focus (EDOF) lens expands presbyopia correction to more patients and joins TECNIS Synergy IOL, a high-performance hybrid lens designed for spectacle independence, in the InteliLight portfolio.

The outlook for the intraocular lens market looks quite promising due to an increasing geriatric population and cases of cataract, technological advancements in IOLs, increased access to care, continued investment in promotion and customer education by IOL manufacturers across the world, a growing number of eye care professionals and dedicated eye hospitals, improving technology access and better patient awareness, and increasing government initiatives and awareness initiatives to control and treat blindness.

Competitive Landscape Analysis: Intraocular Lens Market

The intraocular lens market is marked by the presence of established market players such as Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Zeiss. Other players operating in the market are HOYA Surgical Optics, BVI (Subsidiary - PhysIOL), Rayner Intraocular Lenses, SAV-IOL, SIFI S.p.A, Ophtec, STAAR Surgical Company, among others.

Get Detailed Insights on Intraocular Lens (IOLs) Market with a Sample Report PDF @ https://meditechinsights.com/intraocular-lens-market/

About Medi-Tech Insights:

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact Us:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com